The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $98.
Diebold Nixdorf, Incorporated
DBD · the NYSE · USD · Market cap $2.3B · 20,000 employees
Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide.
PASS · Titan Ethical · score 70.0At the last full screen
2026-08-26
Screened 2026-08-26 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Diebold Nixdorf, Incorporated holds its Markdown at $67.78. The statistical read favours the sellers, held for 5 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 5 days |
| Price at the screen | $67.78 |
| Valuation | 22.44 trailing · 9.66 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.17 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 24.35% | Below 33% | Interest-bearing debt is just 24.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.75% | Below 33% | Cash held in interest-bearing accounts and securities is 0.8% of assets, under the one-third limit. | Pass |
| Receivables | 25.38% | Below 49% | Money owed to the company is 25.4% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.23% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-08-26 screen. The gold marker is the market price at the same screen. A 47.5% margin of safety to the base estimate.
Third-party analyst targets: 3 covering, consensus None. The average target sits +48% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-26 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsQuiet machines still power daily banking and shopping
Every time someone pulls cash from an ATM or scans groceries at a self-checkout, the hardware and software must work without fuss. Diebold Nixdorf supplies those systems across banks and retailers worldwide through its two core segments. Revenue is expanding at 6 percent, yet the business posts only a 3 percent profit margin and an 11 percent return on equity, which leaves little room for error.
The shares trade at 12.6 times forward earnings with a 17 percent gap to our fair value of 100 dollars, and the ethical screen is cleared. Three analysts see the same 100-dollar median target, yet our opportunity rating stays at none because the growth and returns do not clear the threshold for conviction.
Unknown competitive protection and exposure to capital-spending cycles at banks and retailers add real uncertainty. Thin margins can shrink quickly if hardware demand softens or if larger rivals win renewals. Analysis, not advice.
| Forward P/E | 9.7xexpensive even after accounting for its growth |
| Trailing P/E | 22.4xa premium valuation |
| EPS, trailing | 3.02 |
| EPS, forward | 7.02 |
| Revenue growth | +1.7%slow but positive growth |
| Profit margin | 2.9%barely profitable |
| Return on equity | 10.9%a modest return on shareholder capital |
| FCF yield | 13.56% |
| Debt to equity | 1.14a meaningful debt load worth watching |
| Current ratio | 1.27adequate liquidity, worth monitoring |
| Beta | 1.17moves a little more than the market |
| Short interest, float | 0.18% |
| 52-week range | 54.48 - 92.09 |
| Market cap | $2.3B |
| Employees | 20,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDBD trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $98.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 59%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it none, with a mean price target of $98.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $77.48 | +5.0% | · | $1,050 | +5.0% |
| 2 months | $84.78 | -4.1% | · | $959 | -4.1% |
| 3 months | $73.19 | +11.1% | · | $1,111 | +11.1% |
| 6 months | $67.65 | +20.2% | · | $1,202 | +20.2% |
| 1 year | $51.01 | +59.4% | · | $1,594 | +59.4% |
| 2 years | $41.69 | +95.1% | · | $1,951 | +95.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DBD does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.